National Psoriasis Foundation: “CBD for Psoriasis and PsA. “
FDA: “What you need to know (and what we are working to find out) about products containing cannabis or compounds derived from cannabis, including CBD”, “FDA warns 15 companies for illegally selling various products containing cannabidiol, as agency details safety concerns, “FDA warns companies illegally selling over-the-counter CBD products for pain relief.”
Karger’s Notebooks: “Efficacy and safety of a shampoo containing broad-spectrum cannabidiol in the treatment of scalp inflammation in patients with mild to moderate scalp psoriasis or seborrheic dermatitis.” “
The Therapeutic Clinic: “Anandamide suppresses pro-inflammatory T cell responses in vitro through inhibition of mTOR mediated by cannabinoid type 1 receptors in human keratinocytes.”
JAMA: “Clarification of the labeling of cannabidiol extracts sold online.”
Cedars Sinai: “CBD: What You Should Know Before You Try. “
Adam Friedman, MD, professor and president of dermatology, George Washington School of Medicine and Health Sciences.
Joel Gelfand, MD, professor of dermatology and epidemiology; Vice-President of Clinical Research and Medical Director, Dermatology Clinical Studies Unit; Director, Psoriasis Treatment and Phototherapy Center, Perelman School of Medicine, University of Pennsylvania.
James Ralston, MD, McKinney Center for Dermatology, McKinney, TX.
Jim Snedden, 55, Goshen, New York State.
Cynthia Covert, 52, Moreno Valley, Calif.
Our sincere thanks to